max和藥時曲線下面積AUC(0-24h)、AUC(0-∞)均隨給藥劑量的增加而增大,Cmax、AUC(0-24h)和AUC(0-∞)三者均與劑量呈線性相關(guān),各劑量組t1/2Z、Tmax、CLz和Vz均較為一致。與單次給藥相比,食蟹猴多次sc給藥后的t1/2z有所延長但其他主要PK參數(shù)(Tmax、Vz和CLz等)均較為一致,多次給藥后,體內(nèi)藥物無蓄積傾向。結(jié)論 食蟹猴單次sc FGF-21后,在150~600 μg/kg劑量范圍內(nèi)呈現(xiàn)線性動力學特征。單次與多次sc給予FGF-21后,兩者的PK行為特征基本一致,無明顯藥物蓄積。;Objective The pharmacokinetic profile of recombinant human fibroblastgrowth factor-21(FGF-21) for injection after single and multiple subcutaneous administration in cynomolgus monkeys was studied. Methods 18 cynomolgus monkeys were administered subcutaneously at single dose of 150, 300, 600 μg/kg FGF-21 or multiple dose of 300 μg/kg in a randomized design, parallel and dose-escalation study. ELISA method was developed to determine the dynamic changes of drug concentration in serum, and pharmacokinetic parameters were calculated by using DAS 3.2.4 pharmacokinetics program. Results Pharmacokinetic parameters in cynomolgus monkeys between different single dose groups are as follows:Cmax, AUC(0-24 h) and AUC(0-∞) were positively proportional linear related with increasing dose.t1/2Z, Tmax, CLz, and Vz were all consistent in each dose groups. Compared with single administration, the t1/2z of cynomolgus monkeys was prolonged after multiple administrations, but other major PK parameters (Tmax, Vz, CLz) were consistent. After repeated administration, there was no accumulation tendency of drugs in body. Conclusion FGF-21 administered subcutaneously at single dose of 150-600 μg/kg in cynomolgus monkeys exhibits linear pharmacokinetics. The characteristics of pharmacokinetics are basically consistent with single and multiple dose of 300 μg/kg FGF-21, indicating that no significant drug accumulation was ovserved."/>

醉酒后少妇被疯狂内射视频,一本色道久久综合一,在线天堂新版资源www在线下载,中文字幕乱人伦高清视频,中字幕视频在线永久在线观看免费

首頁 > 過刊瀏覽>2019年第42卷第9期 >2019,42(9):1774-1779. DOI:10.7501/j.issn.1674-6376.2019.09.011
上一篇 | 下一篇

注射用重組人成纖維細胞生長因子-21食蟹猴藥動學研究

Pharmacokinetics of recombinant human fibroblast growth factor-21 in cynomolgus monkey for injection

發(fā)布日期:2019-09-29
您是第位訪問者
藥物評價研究 ® 2025 版權(quán)所有
技術(shù)支持:北京勤云科技發(fā)展有限公司
津備案:津ICP備13000267號 互聯(lián)網(wǎng)藥品信息服務(wù)資格證書編號:(津)-非經(jīng)營性-2015-0031